These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16103201)

  • 1. Replication of varicella-zoster virus in human skin organ culture.
    Taylor SL; Moffat JF
    J Virol; 2005 Sep; 79(17):11501-6. PubMed ID: 16103201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.
    Lloyd MG; Smith NA; Tighe M; Travis KL; Liu D; Upadhyaya PK; Kinchington PR; Chan GC; Moffat JF
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Associated Differences in Infection of Human Skin in the SCID Mouse Model of Varicella-Zoster Virus Pathogenesis.
    Zerboni L; Sung P; Lee G; Arvin A
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine use of a highly automated and internally controlled real-time PCR assay for the diagnosis of herpes simplex and varicella-zoster virus infections.
    Stránská R; Schuurman R; de Vos M; van Loon AM
    J Clin Virol; 2004 May; 30(1):39-44. PubMed ID: 15072752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella-zoster virus infection of a human CD4-positive T-cell line.
    Zerboni L; Sommer M; Ware CF; Arvin AM
    Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key issues in varicella-zoster virus latency.
    Kennedy PG
    J Neurovirol; 2002 Dec; 8 Suppl 2():80-4. PubMed ID: 12491156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster.
    Chen JJ; Zhu Z; Gershon AA; Gershon MD
    Cell; 2004 Dec; 119(7):915-26. PubMed ID: 15620351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections.
    Levin MJ
    J Clin Virol; 2014 Dec; 61(4):487-95. PubMed ID: 25453570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Biology of Varicella-Zoster Virus Replication in the Skin.
    Tommasi C; Breuer J
    Viruses; 2022 May; 14(5):. PubMed ID: 35632723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Robust Varicella Zoster Virus Luciferase Reporter Viruses for In Vivo Monitoring of Virus Growth and Its Antiviral Inhibition in Culture, Skin, and Humanized Mice.
    Lloyd MG; Yee MB; Flot JS; Liu D; Geiler BW; Kinchington PR; Moffat JF
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers.
    Ku CC; Padilla JA; Grose C; Butcher EC; Arvin AM
    J Virol; 2002 Nov; 76(22):11425-33. PubMed ID: 12388703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system.
    Zhang Z; Rowe J; Wang W; Sommer M; Arvin A; Moffat J; Zhu H
    J Virol; 2007 Sep; 81(17):9024-33. PubMed ID: 17581997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing quantitative isolation of varicella-zoster virus.
    Levin MJ; Leventhal S; Masters HA
    J Clin Microbiol; 1984 Jun; 19(6):880-3. PubMed ID: 6088572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of varicella zoster virus in Raji cells.
    Cauda R; Chatterjee S; Tilden AB; Grossi CE; Whitley RJ
    Virus Res; 1986 Jun; 4(4):337-42. PubMed ID: 3014780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
    Arvin AM
    Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a rodent model to show that varicella-zoster virus ORF61 is dispensable for establishment of latency.
    Sato H; Pesnicak L; Cohen JI
    J Med Virol; 2003; 70 Suppl 1():S79-81. PubMed ID: 12627493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.